Investigación / Grupos de investigación

Grupo  3

Enfermedades Sistémicas de Base Autoinmune

Publicaciones (390)

  • Murias S; Boteanu A; Calvo I; Nuñez E; Bravo B; Bustabad S; Camacho M; Clemente D; Graña J; de Inocencio J; Lacruz L; Mesa-Del-Castillo P; Nieto-González JC; Pinedo MDC; Quesada E; Vargas C; Antón J.

    What drives the decision to optimise biological treatment in children and youngsters with juvenile idiopathic arthritis? A discrete-choice experiment.

    Reumatologia Clinica. 2023; 19(1): 26-33 [doi:10.1016/j.reumae.2022.11.002]

  • Murias, S; Boteanu, A; Calvo, I; Nunez, E; Bravo, B; Bustabad, S; Camacho, M; Clemente, D; Grana, J; de Inocencio, J; Lacruz, L; Mesa-del-Castillo, P; Nieto-Gonzalez, JC; Pinedo, MD; Quesada, E; Vargas, C; Anton, J.

    What drives the decision to optimise biological treatment in children and youngsters with juvenile idiopathic arthritis? A discrete-choice experiment

    Reumatologia Clinica. 2023; 19(1): 26-33 Nº de citas: 1 [doi:10.1016/j.reuma.2021.12.003]

  • Fernandez-Carballido, C; Sanchez-Piedra, C; Valls, R; Garg, K; Sanchez-Alonso, F; Artigas, L; Mas, JM; Jovani, V; Manrique, S; Campos, C; Freire, M; Martinez-Gonzalez, O; Castrejon, I; Perella, C; Coma, M; Van der Horst-Bruinsma, IE.

    Female Sex, Age, and Unfavorable Response to Tumor Necrosis Factor Inhibitors in Patients With Axial Spondyloarthritis: Results of Statistical and Artificial Intelligence-Based Data Analyses of a National Multicenter Prospective Registry

    ARTHRITIS CARE & RESEARCH. 2023; 75(1): 115-124 Nº de citas: 5 [doi:10.1002/acr.25048]

  • Martin-Lopez, M; Galindo, M; Pego-Reigosa, JM; Jimenez, N; Marques, AO; Tomero, E; Freire, M; Martinez-Barrio, J; Boteanu, A; Salgado-Perez, E; Fernandez-Nebro, A; Calvo, J; Menor-Almagro, R; Rua-Figueroa, I.

    Clinical characteristics and risk factors associated with lymphoma in patients with systemic lupus erythematosus: a nationwide cohort study

    RHEUMATOLOGY. 2022; 62(1): 217-224 Nº de citas: 4 [doi:10.1093/rheumatology/keac258]

  • Narvaez, J; Fontecha, PDD; Garcia, NB; Bonilla, G; Aburto, M; Castellvi, I; Cano-Jimenez, E; Mena-Vazquez, N; Nieto, MA; Ortiz, AM; Valenzuela, C; Hernandez, MAA; Castrejon, I; Plaza, MC; Hernandez, FMF; Hernandez, MVH; Portal, JAR.

    SER-SEPAR recommendations for the management of rheumatoid arthritis-related interstitial lung disease. Part 2: Treatment

    Reumatologia Clinica. 2022; 18(9): 501-512 Nº de citas: 2

  • Molina-Collada, J; Gloria, KL; Castrejon, I; Nieto-Gonzalez, JC; Martinez-Barrio, J; Alfaro, AMA; Rivera, J; Alvaro-Gracia, JM.

    Impact of cardiovascular risk on the diagnostic accuracy of the ultrasound Halo Score for giant cell arteritis

    ARTHRITIS RESEARCH & THERAPY. 2022; 24(1): Nº de citas: 7 [doi:10.1186/s13075-022-02920-9]

  • Sanchez-Piedra, C; Alvaro-Gracia, JM; Bustabad-Reyes, S; Diaz-Gonzalez, F.

    The reality of Rheumatology in Spain and its autonomous communities before the pandemic

    Reumatologia Clinica. 2022; 18(8): 486-489

  • Gonzalez, COS; Gonzalez, JCN.

    JAK kinase inhibitors and varicella zoster virus infection in patients with rheumatoid arthritis. Systematic review of the literature

    Reumatologia Clinica. 2022; 18(8): 453-458

  • Portal, JAR; Garcia, NB; Fontecha, PDD; Valenzuela, C; Ortiz, AM; Nieto, MA; Mena-Vazquez, N; Cano-Jimenez, E; Castellvi, I; Aburto, M; Bonilla, G; Hernandez, MVH; Hernandez, FMF; Plaza, MC; Castrejon, I; Hernandez, MAA; Narvaez, J.

    SER-SEPAR recommendations for the management of rheumatoid arthritis-related interstitial lung disease. Part 1: Epidemiology, risk factors and prognosis

    Reumatologia Clinica. 2022; 18(8): 443-452 Nº de citas: 2

  • Antela, A; Bernardino, JI; de Quiros, JCLB; Bachiller, P; Fuster-RuizdeApodaca, MJ; Puig, J; Rodriguez, S; Castrejon, I; Alvarez, B; Hermenegildo, M.

    Patient-Reported Outcomes (PROs) in HIV Infection: Points to Consider and Challenges

    Infectious Diseases and Therapy. 2022; 11(5): 2017-2033 Nº de citas: 7 [doi:10.1007/s40121-022-00678-w]

  • Lopez-Gloria, K; Castrejon, I; Nieto-Gonzalez, JC; Rodriguez-Merlos, P; Serrano-Benavente, B; Gonzalez, CM; Saez, IM; Gonzalez, T; Alvaro-Gracia, JM; Molina-Collada, J.

    Ultrasound intima media thickness cut-off values for cranial and extracranial arteries in patients with suspected giant cell arteritis

    Frontiers In Medicine. 2022; 9: Nº de citas: 21 [doi:10.3389/fmed.2022.981804]

  • Castaneda, S; Gomez-Alonso, C; Grana, J; Guanabens, N; Munoz-Torres, M; Peris, P; Naves, M; Alvaro-Gracia, JM.

    Position of the Spanish Society of Rheumatology (SER) and the Spanish Society for Bone Research and Mineral Metabolism (SEIOMM) on romosozumab

    Reumatologia Clinica. 2022; 18(7): 383-386

  • Moreno-Ramos, MJ; Sanchez-Piedra, C; Martinez-Gonzalez, O; Rodriguez-Lozano, C; Perez-Garcia, C; Freire, M; Campos, C; Caliz-Caliz, R; Calvo, J; Blanco-Madrigal, JM; Perez-Gomez, A; Moreno-Martinez, MJ; Linares, L; Sanchez-Alonso, F; Sastre, C; Castrejon, I.

    Real-World Effectiveness and Treatment Retention of Secukinumab in Patients with Psoriatic Arthritis and Axial Spondyloarthritis: A Descriptive Observational Analysis of the Spanish BIOBADASER Registry

    Rheumatology and Therapy. 2022; 9(4): 1031-1047 Nº de citas: 10 [doi:10.1007/s40744-022-00446-9]

  • Romero-Jimenez, R; Escudero-Vilaplana, V; Chamorro-de-Vega, E; Ais-Larisgoitia, A; Lobato-Matilla, E; Somoza-Fernandez, B; Ruiz-Briones, P; Gonzalez, C; Baniandres, O; Menchen, L; Lobo-Rodriguez, C; Herranz, A; Sanjurjo, M.

    Design and implementation of a mobile app for the pharmacotherapeutic follow-up of patients diagnosed with immune-mediated inflammatory diseases: eMidCare

    Frontiers in Immunology. 2022; 13: Nº de citas: 3 [doi:10.3389/fimmu.2022.915578]

  • Molina Collada J; Mayordomo L.

    Perceived quality of training in musculoskeletal ultrasound in Spanish rheumatology services.

    Reumatologia Clinica. 2022; 18(6): 349-354 [doi:10.1016/j.reumae.2021.01.003]

  • Pombo-Suarez, M; Sanchez-Piedra, C; Ruiz-Montesino, D; Diaz-Torne, C; Jovani, V; Cea-Calvo, L; Castrejon, I.

    Retention of golimumab treatment following discontinuation of non-TNF inhibitors in patients with inflammatory rheumatic diseases: An analysis of the Spanish BIOBADASER registry

    Musculoskeletal care. 2022; 20(2): 403-407 Nº de citas: 1 [doi:10.1002/msc.1595]

  • Rivera, J; Rodriguez, T; Pallares, M; Castrejon, I; Gonzalez, T; Vallejo-Slocker, L; Molina-Collada, J; Montero, F; Arias, A; Vallejo, MA; Alvaro-Gracia, JM; Collado, A.

    Prevalence of post-COVID-19 in patients with fibromyalgia: a comparative study with other inflammatory and autoimmune rheumatic diseases

    BMC MUSCULOSKELETAL DISORDERS. 2022; 23(1): Nº de citas: 8 [doi:10.1186/s12891-022-05436-0]

  • Collada, JM; Macia-Villa, C; Plasencia-Rodriguez, C; Alvaro-Gracia, JM; de Miguel, E.

    Ultrasound Doppler enthesitis shows sensitivity to change after biological therapy in spondyloarthritis and psoriatic arthritis patients

    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY. 2022; 51(3): 1-9 Nº de citas: 4 [doi:10.1080/03009742.2021.1921348]